Your SlideShare is downloading. ×
West nile virus infections – pipeline review, h1 2012
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

West nile virus infections – pipeline review, h1 2012

177

Published on

Aarkstore.com | West Nile Virus Infections – Pipeline Review, H1 2012 || Market Research

Aarkstore.com | West Nile Virus Infections – Pipeline Review, H1 2012 || Market Research

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
177
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:West Nile Virus Infections – Pipeline Review, H1 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, West Nile Virus Infections - Pipeline Review, H1 2012,provides an overview of the West Nile Virus Infections therapeutic pipeline. Thisreport provides information on the therapeutic development for West Nile VirusInfections, complete with latest updates, and special features on late-stage anddiscontinued projects. It also reviews key players involved in the therapeuticdevelopment for West Nile Virus Infections. West Nile Virus Infections - PipelineReview, H1 2012 is built using data and information sourced from Global MarketsDirect’s proprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for West Nile Virus Infections.- A review of the West Nile Virus Infections products under development bycompanies and universities/research institutes based on information derived fromcompany and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.
  • 2. - A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Table of contents:List of Tables 3List of Figures 4Introduction 5Global Markets Direct Report Coverage 5West Nile Virus Infections Overview 6Therapeutics Development 7An Overview of Pipeline Products for West Nile Virus Infections 7West Nile Virus Infections Therapeutics under Development by Companies 9Late Stage Products 10Comparative Analysis 10Mid Clinical Stage Products 11Comparative Analysis 11Pre-Clinical Stage Products 12Comparative Analysis 12West Nile Virus Infections Therapeutics – Products under Development byCompanies 13Companies Involved in West Nile Virus Infections Therapeutics Development 14CEL-SCI Corporation 14Hemispherx Biopharma, Inc. 15BioMAS Ltd. 16MacroGenics, Inc. 17West Nile Virus Infections – Therapeutics Assessment 18Assessment by Monotherapy Products 18Assessment by Route of Administration 19Assessment by Molecule Type 21Drug Profiles 23ChimeriVax-West Nile - Drug Profile 23Product Description 23Mechanism of Action 23R&D Progress 23Alferon N Injection - Drug Profile 24
  • 3. Product Description 24Mechanism of Action 24R&D Progress 24CEL-1000 - Drug Profile 25Product Description 25Mechanism of Action 25R&D Progress 26AS101 - Drug Profile 28Product Description 28Mechanism of Action 28R&D Progress 28MGAWN1 - Drug Profile 30Product Description 30Mechanism of Action 30R&D Progress 30West Nile Virus Infections Therapeutics – Drug Profile Updates 31West Nile Virus Infections Therapeutics - Dormant Products 32West Nile Virus Infections – Product Development Milestones 33Featured News & Press Releases 33Sep 06, 2011: Hemispherx Enters Into Strategic Alliance With Armada Health CareFor Alferon N Injection 33Appendix 34Methodology 34Coverage 34Secondary Research 34Primary Research 34Expert Panel Validation 34Contact Us 35Disclaimer 35List of FiguresList of Tables are also include.
  • 4. For more related Reports Plz follow The link:Pipeline Review, H1 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H12012&PubId=&pagenum=1Tachycardia (Tachyarrhythmias) – Pipeline Review, H1 2012Genital Warts (Condylomata Acuminata) – Pipeline Review, H1 2012Gingivitis – Pipeline Review, H1 2012West Nile Virus Infections – Pipeline Review, H1 2012Pompe Disease – Pipeline Review, H1 2012Bronchiolitis Obliterans – Pipeline Review, H1 2012Cancer Cachexia – Pipeline Review, H1 2012Hyperuricemia – Pipeline Review, H1 2012Sarcoidosis – Pipeline Review, H1 2012Optic Nerve Injury – Pipeline Review, H1 2012Search More Reports Related to This Category :
  • 5. Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×